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~~lve’ropbxemcn, in = 3io;arrhythia surgery [n = 71) was 
wlormed. Al, p&en& in group 1 were clinically stable b&e 
surgery, receivkg an anfiarrhythmic rogimcn cbmen by serial 
dme ,e*fincp. The wne reeimen was confinued 00stol~ra,,~ek. 
&h, oy,hc 46 patients:” group t whose condition had b&n 
slable in Ibe hospital For 19 + 26 dayr prmpwatively developfd 
multiple episode of surtaiiied veniricular tachycardia 4 I 9 days 
aher implantation white receiving the same antinrrbythmla regt. 
mm. Allhough the exacerbation was lransien, in ~lmc patients, 
six resuired different andarrhrlhmic theraw and one ~wntuall~ 
dind. Two additional patients had Frequent and pmlanged epi- 
r&s of nansustained ventricular tachycardia [ha, could trigger 
fhe dctibrillalor, requiring changes in [be antifirrhylbmic regt. 
men. Bnotber patient bad progresrkc :ardiac Failure and died on 
Implxnable aurumauc defibrilbxorr (I-81 have been used 
widely For the management of patienls with malignan, 
ven,ricul.x errbyrhmias and ,hw beneficial effect in pre- 
veodng sudden cardiac death has been Frequenlly reporlcd 
(I-61 However. ,hc monality raw of ,hr operation is 
noi insignificant and infection frequently occurs (5.7, 
9.10). In addilion. several investigalors (5.7.9.10) have 
noled intractable ventricular tachycardia aflcr defibrillator 
inplanialion This wdy WBC undertahen 10 investigate 
ihe irewency and nalure uf wonening of v-_nu~cubx ar. 
rhvhmia durmp rhe po\,operative period after defibrillator 
mipidniaiion 
day 5. A marked (sawnFold) increase ina;rympbmatic Yentricular 
arrhv,bmlar was noted in 41% OF the remainine 35 wtiene. 
I. gm~p 2 (combinfd surgery), ~lle patent d&pfd hat. 
tory wn,ricu,ar ,achycsrdiQ 3 days pmtoperr&e,y and dii an 
that day. Three patimls doveto@ Frequen, nonsustained ventric. 
ular tschycmdts posttapralivrly, requiring changes in the anIl- 
arrbytbmic reghen. The overall surgical mortality rate was 4.4% 
Thus, during the postop&e period afler defibrillator im- 
plpntntion, rxacerb&m of ventricular arrhythmias WI common. 
The exacwhation was ctinicalty sigl)iticant in many patients and 
included mullipte episodes oF sustained ventricular tachycardia 
,w,,h evenrua, death in some palierds) or Frequent prolngd 
nonwslained ventricular taehyrardia that rwld trigger the de. 
6hrillstor. r\ sevenfold arymptomattc increw in wdrieuhr 
ectoplr activlly was noted in 42% olthe remaining clinir*,y s&Me 
pstients. Thr ,ong.,erm efk, al Ihe exacerhatbm k ~“,‘“o,v”. 
Methods 
Study patients. Sixty-eight consecutive patients who un- 
derwn, implantation of an a.u,oma,ic defibrillator for malig- 
nant ventriculararrbylhmias a, Mometiore Hospital Medical 
Center between May I. 1982 and December 31. l9W were 
swdied. Informed consent was ob,ained From all palients for 
implanta,ion of ,he delibrillatur. During the period when 
implantable defibrillalors were inves,iga,ional. the proce- 
dure was perlormed under the inves,iga,ional prolocol ap 
proved by [he Instiuuonal Research Review Commiltee in 
April 1982. The wdy was a retrospective analysis of pro. 
speclively obtained &ala in 34 patiems during rhe period 
between May I. I982 and December 31, 1987 and prospec- 
tive in 34 p&n,\ thereafter. 
Fwl!-rir p&m fprmp I I underwent defibrillator implan- 
tation wilhou, concomiran, surgery and 22 patients lgroup 2) 
had concomkm, sulyery. Fourken pa,ien,s had concombam 
coronary bypan surgery: I;pc of lhere patients also had mitral 
valve replacement. Seven pdlien,~ had concomilan, surgery For 
arrhylhmiar such as wbendocardial resection (n = 5) (I I,, 
cryasurgery I” = II II?) or sep,al myomec,“my (” = I) (131. 
One oatient had mitral value replacement. The 22 panent~ with 
concomitant surgery Croup 21 vcre analyzed separately for the 
purpose of this study. 
In group 1. 27 patients had sustained ventricular tachy- 
cardia and 19 had ventricular fibrillatmn. Susramed venmc- 
ular tachycardia was defined as Ming >30 5 or requiring 
immediate termination by electric cardiovenivn became of a 
hemodynamic collapse. there were 35 men and I I women. 
with a mean age of 58 2 I I years. Coronary anery dwzase 
was Present in 33 patients. ddatcd cardiomyoparhy in 7. 
valvuiar heart disease in 4 and amyloid hearc disease in 2. 
The mean left ventricular ejection fraction wns 32 5 1% 
In group 2. there were I6 men and 6 women. with a mean 
age of 62 t IO years. Eighteen patients had surtained 
ventricular tachycardm and four had ventricular fibrillation. 
Cornnary artery disease was piesent in t9 patvents tmitral 
regurgitation in 2). dilated cardiomyopathy in I. valvular 
heart disease in I and hypertrophic cardiomyopathy in 1. 
The mean left vemricular ejection fraction was 37 + 16%. 
An&rhythmic therapy Mm the implantation. All 68 
patients underwent serial drug testing by programmed stim- 
ulation and ambulatory clcctrocardiographw (ECG) momtor- 
ing (14-18). An antiarrhythmic regimen was selected on Ihe 
basis of the resultr of wial ten,mg. Although the reg~mem 
were considered ineffective by serial drug testing. all pa- 
tients were in stable condition without spontaneous recur- 
rence of symptomatic ventricular arrhythmms u hdc rcceiv- 
ing these antiarrhythmic regimens during rhc hosplral stay 
before the defibrillator implantation. 
Defibrillator therapy was not given to patients whose 
ventricular tachycardia Induced by pmgnmmed stimulation 
became slower and better tolerated during drug therapy and 
whose spontaneous arrhythmias were reduced during amhu- 
latorv monitorine (15-181. Defibrillator theraov was also not 
given to patients&hose frequent ~pontaneouf ~ccurrcnces of 
ventricular tachycardia could not be controlled by drug 
therapy. 
Antiarrhythmic therapy during the Pastoprative period. 
All patients except those who had subendocwdial resection 
received intravenous lidocaine or procainamide during the 
immediate postoperative period. The antiarrhythmic repi- 
men chosen by preoperdtivc drug testing was reintroduced 
when the p&tier& was able to take medic&ion by mouth. If a 
Patienr had recurrent sustained ventricular tachycrrdia while 
receiving intmvenous medicatton postoperatively. admmis- 
tmtion of the oral antiarrhythmic drug chosen prcoperativcly 
was reinstituted. If a patient had recurrent vcntriculur txhy- 
cardia during the postopera:ive Period while rcceivmg the 
same oml antiarrhvthmic ~ee~men and had blood levels 
similar 10 preoper&e Iev&. B differenr antiarrhythmic 
regimen was Prescribed. Similarly. if a patient had frequent 
episodes of rapid nonsustnined ventricular tachycardio Pwt- 
operatively while rccciwng the rcg~men that wn’i effective 
preoperatively. a different antiarrhythmlc regimen wns mrti- 
tutcd to prevent rriggcring of the defihrdlator by such ar- 
rhylhmms (6). The dccirion 10 change !he anriarrhylhmx 
regimen m peoent~ with frequent nonsustained ventricular 
lachycardia was not bavd on quantitative assessments by 
ambulatory E’% monitoring. but on findings on the teleme- 
try momtor and clinical Judgmenr of rhe investigators. In 
ceven parwnn who had concomitant surgery for arrhyth- 
ma*. antiarrh?thmic drug therapy was chosen on the basis 
of no5loncrauw drue w5tine 
Cam&son of a~hythmii bpfore and after operation. 
Ambularov (ECCI monitoring and bedside telemetry were 
used 10 compare ventricular arrhythmias noted before and 
nfrer opermmo. The preoperative ambulatory ECC record- 
ing obtained able a patient was receiving an antmrrhylhmic 
regimen chosen by preo~ratwe serial tcstmg was compared 
with the oostowrative rccordine obtained while rhe patient 
was receiving the %mr bntia~h$hmic regimen. 
Implantation of M automatic defihriUatw. In group I. all 
46 patients underwent defibrillator implantation without 
comcomnunt surgery. The electrode-lead system used in- 
cluded a sonne-oatch co&u&m (6) in 6 ken& a 
Patch-patch’ co&uratioa (61-i” 37 and a trans&us lead- 
subcutaneous watch configuration (Endotak) (191 in 3. A 
median s’erno~omy (61 was used in 39 parienrs. a lawal 
thoracotomy (61 was used in 3 patients. a subcosral approach 
(6) wa used 10 1 patient and tmnswnous and subcutaneous 
approach (for Endotakt (191 was used in 3 pirtients. In group 
2. I4 pahents had coronary bypass surgery (with mitral valve 
replacement in ?I. I Patient had mitral valve replacemcm. 5 
oaoents had subendocardial resection. I mien1 had semal 
myomectomy and I had epicardial cryoablation during’de- 
fihrdlntor implanration. The spring-patch configuration (6) 
was used in 2 paoents and the patch-patch configuration in 
20. All 22 patienlr had a medtan stermxomy. 
Evaluation of pmtoprralive ventricuku arrhythmias in a 
control group. To assess effects of coronary bypass surgery 
on portoperat~re ventricular arrhythmias, 20 consecutive 
paoemr who underwent coronary bypass rurgery wirhom 
defibrilbror implantation were studied by ambulatory ECG 
monitoring hcforc and after opration. Patients with a recent 
t<? weeks) myocardial infarction or left main coronary 
artery disease were excluded from the study. 
Ambulatory ECC monitoring. The technique and accu- 
racy of 24-h ambulatory ECG monitoring used in this study 
have been puhhshed (161. Nonsustained ventriculx tachy- 
cardia wus defined as three or more consecutive ventricular 
premature complexes ar a rate ?IW hc&min. 
Statirlical methods. Standard deviarion (mean Z SD) was 
used as the index of dispersion of observed values. One-way 
analyn, of wriance IANOVAL the Kruskat-Wallis test or 
chl-quare test \\as urcd to compare appropriate variables 
between groups. A two-tailed P value <O.OS was considered 
ugmlant. 
RIZ.SUltS 
Drug therapy before qwation (group 1). Antiarrhythmic 
therapy w;~~gwen to41 ofthe patients before defibrillator 
implantation. In five patients, no anliarrhylhmic agents were 
given because no therapy was considered beneficial by 
invasive or noninvasive evaluation of antiwrhythmic et% 
cxy (12-161. A class IA anent (txocainamide. auinidine or 
disopyramide) was used in six &ents, a class IB agent 
(mexiktine or tocainide) in seven. a combination of class IA 
and IS agents in nine, a beta-adrenergic blocking agent in 
four. amiodarone in eight. a combination of a class IA agent 
and a beta-blocker in five, satalol in one patient and a 
combination of amiodarone and a class IA agent in one. 
Postoperative court (group 1) (Tables 1 and 2, Fig. I). 
Eight of the 46 patients who had been in stable condition for 
19 + 25 days in the hospital developed sustained ventricular 
tacbycardia 4 + 9 days postoperatively. All patients except 
one (Patient 3) had mulriple recut’rences during the p&cd 
(Table IL Two patients (Patients 5 and 8) whose ventricular 
arrhythmia improved gradually were discharged from the 
hospital receiving the same antiarrhythmic regimen chosen 
before operation. In live patients. an additional or di6erent 
atttiarrh~tbmic agent (am~odarotte in two patients) was used 
to stabilize the arrhythmia. One txxient IPatient 4) died in the 
hospital as a result of refract& ventricular tachycardia. 
Antiarrhythmic regimen and blood levels before the implan- 
tation, blood levels of the saute drugs after implantation ~.t 
the time of recurrence and the final regimen at the time of 
discharge from the hospital are shown in Table 2. 
In two other patients (Fig. II. an additional antiarrhyth- 
mic agent (quinidine or tocainide. respectively) was used to 
suppress frequent nonsustained ventricular tachycardia 
noted postoperatively that could trigger the d?tib;ill~iot. The 
frequency of nonsustained ventricular tachycardia by ambu- 
latory ECG recording was not quanlitalively assessed before 
the change in therapy. The decision was made by the 
investigators on the basis of the patients’ clinical condition. 
After additional antianhythmic therapy. one patient no 
longer had nonsustained ventricular tachycardia. In the 
other patient, who was Ming quinidine, the addition of 
tocainide mark& decreased the freauencv of nonsustained . . 
ventricular tachycardia s judged by bedside telemetry tnon- 
itoring. An ambulatory ECG recording obtained 7 days 
postoperatively while the patient ~8s taking tocainide and 
‘Tab* 2. Andarrhythmic Regimens and B&d Levels in Eight 
Patients With Recurrent Ventricular Tachycardia After 
DeRbrillator lmolantation 
quinidine revealed I I4 runs of noncu~rrned ventricular 
tachycardia as compared with 35 runs preuperatively during 
administration of quinidine alone. 
In swnmn~. the antiarrhythmic regimen chosen before 
operation had to be changed dunng the pouoperauve period 
because of suslained ventricular tnchycardra or frequent 
nonsustained ventricular tachycardia in IO I??%) of the of 46 
patients. In 2 of these IO patients. the regimen choxn 
preoperatively could be reinslitutcd ruh\equeotl>. One pa- 
tient developed progressive cardiac failure postoperatively 
without recurrent ventricular Vachycardia snd dted on d;iy 5. 
The remuining 3S puiewl.5 ww rlkrkall~ .3rd~k powp- 
erolisel~, wei@ rhc nnfbrrhnlm~ir nym~~~~~ dmcm p, r- 
opcratisrly. Rerulrx of ambulatory ECG momtoring per- 
formed 4 + 5 days after operation were compared M,ith the 
monitoring results obtained preopemtively whde the pahent\ 
were receiving the sane regimen. In two pottentc. povoper- 
alive ambulatory ECG recording rw attempted hut not 
obtained beawse of recorder malfuunction\. Before opera- 
tion. there was an average of 21.3 = 42. I ventricular 
premature complewlh and 0.24 5 0.56 episode of nonw- 
lained ventticular tachycurdiaQ4 h. Po~toperauvely. the 
average ventricular premature complc’tesrh increased to 
74.5 + I54.Y (p < n.051 and the iwcragc nonsu%tained 
ventricular tachycardri24 h mr‘reased to 1.X f 3.6 Ip C 
0.02). When individual pataent* were compared. a wventald 
increase in ventriculilr prcmilturc complex\ (201 w\ noted 
in 14 (42%) of 33 patients who had matched dmhuiatary ECG 
recordings bsfurr and after operation while recwmg the 
same antiarrhythmlc regmten IFig. IL Nonruswned vcntric- 
ulsr rrchycardla war prexnt in 6 of the 33 pauentx preoper- 
atlvely and Ii poQoperattvely Lp C 0.0?1. Antinrrhwhmic 
drug levrl, dnun on the day of postopcratwr ambulatory 
ECG rccordiw were not significantly ddTerent from Ihow 
of the preoperanrc period lqumtdme 3.4 5 1.1 before 
apsrawn Y\. 16 2 1.8 rl@iter after opcra,,on. proc‘wa- 
midc 7 6 5 a.2 VT 7.9 f 5.3 m~‘litcrr. 
Postoperatire clinical ewrse lgroup 21. Twclw parents 
underwent corondn bypass graft ,urgerk durmg defibnllator 
lmplantarion Txo rddltional patient* urth coronary bypw 
wrgx) and mltml salve replacement wre not included m 
thl\ wbgroup. Before operation. three pauents were reccw 
I”: ,i cliw i:\ agent. three a clas, IB ageen,. ,\,I, horh a clxs 
IA and a cI.w I” agent and one a beta-blocker Three 
pstisnt\ did not rcccive any antiarrhythmlc agent. Puwpcr- 
atlvel~. I of these I? patienta requrcd addnmal anttar- 
rhithmic therapy beaaux of a marked mcre~s.z in nonub- 
tamed ventricular tachpcardia 18 runs of nonw,tamcd 
~cnirxular tach>cardra before vs. I.356 run, after opera 
tionl. Fuur of the rcmammg I I patients had a xvsnfold 
I”crc,I\c I” \entncuix premature c0rnplew. 
Tiic J orraii,inv IC pnriena in ~ro~rp 2 rw/fv 11 m! u <w- 
wnurmH ~~prrww ~rliar rhw lw b, rltWiriort ro) corwro~ 
hrm.\ rri~,rtw. Fwe pattents had subendocardml revxt,on. 
one d wpt,d m)omectomy. one epicardval cryosurgery for 
vemncular tachycardia and three mitral ralve replxement 
or repau ,,\(,I \\lth coronary bypa\> surgery,. Tao patients 
wah mad u,il~ i: replacement required an additional antw 
rh!thmlc npent po>toperatixly for frequent episode> of 
npid nonwained vcntrn&utachycardia. One pahem aiih 
ddated c;lrd!umyoptethy and rrcurrcnl well tolerated vu- 
triculilr tach>cardia underwent defibrillator implantation 
and cr~owrSeer! for ventricular tnchycardia originating 
from the epnrdium. Thn patient developed multtple ept- 
rode\ uf &\tcr poorly tolemted ventricular tachycardia and 
~cntncul:u fibrillation 3 days patoperatively and died on 
that day. 
Po~tuperalive course in the control group. Ambulatory 
ECfj rccordmg> were oblained before and after operation in 
20 control pattents who underwent coronary bypass surgery 
uilhoul dcfihrllknor Implantation. The arcrage ventncular 
premature complex frequency was 4.15 t 8.8/h before and 
8 6 I 17 h/h after operation Ip = 0.226l. The number of 
nonwtancd wntricular tachycardias was U z 0124 h before 
and 0.3 : 1.X4 h postopernt~vely lp = 0.333). A sevenfold 
mcreare in rentradar premature complexes was noted in 2 
of the 20 pauen,,. 
Surgiral mnrtality. Three of rhe 6X patients died m the 
ho.pital within 111 days after operahon for a w~icsl mortal- 
sty rxe 171 of 4.4%. This rate was 4.3% (? of46 patientst in 
group I ;md 1.55 t I of 22 patient\) in group 2. Two of the 
three dcathj were due to refractory ventricular txhycardia 
and one I\:,, due to propre\\,vc cardrec failure. 
Discussion 
The results of thic study suggeest that during the postop- 
erative period after deiibrillator implantatmn. 1) a climeally 
significant worsening of ventricular tachyarrhythmia defined 
as muluple recurrences of sustained ventricular tachycardia 
or prolonged rapid cpiaodes of nonsuctamed ventricular 
tachpcardia requiring changer in the antiarrhythmic regimen 
is noted in a significant number of patients. 2) the in-hospital 
mortality rate IS not insignificant and i< often due to the 
worsening of arrhythmias. and 31 a marked increase in the 
frequencv of asvmmomatic ventricular arrhythmias is noted 
in many other patients in clinically stable condition. 
Comparison with other studies. The short-term results of 
our study are similar to those previously reported hy others 
(7.9.10.21). Marchlinski et al. (10) also reported postopera- 
tive refractory ventricular tachycardia and one death. From 
data compiled by a manufacturer of defibrillators. Winkle 
and Thomas 171 reported that 40 (4%) of 949 patients died 
wtthin 1 month aft& implantation Isurgical m&tality): 9 of 
the 40 who died had a sudden cardiac death during the 
postoperauve period. Thirty-one of the 40 patients did not 
have concomitant surgery and 9 had concomitant surgery. 
Therefore. 31 (4.6%l of 669 patients without concomitant 
surgery and 9 (3.2%) of 2x6 patients with concomitant 
surgery died within 30 days postoy;:ratively. It is unclear 
from their report (7) how many of the nine patients who died 
suddenly had concomitant surgery. In a study of 271 patients 
by Gohn et al. IZIL the surgical monality rate was 4% and 
58.4% of surgical deaths were due to “arrhythmic compli- 
cations.” They (21) also repotted that concomitant surgery 
during defibrillator implantation was not a determinant of 
surgical mortali!y. These investigators (7,10,2lL however. 
did not report the total incidence of malignant ventricular 
arrhythmias, including ventricular tachycardia successfully 
treated in the hospital as reported in our study. In a study of 
IO1 uatients, Gartman et al. 19) rerroned that 11% of oatiena 
had’sustained ventricular tachycardia postoperatively as 
compared with 13% in our study I9 of 68 patients: gin group 
I and I in group 21. Their surgical mortality rate was 4%. 
However. they did not report the incidence of worsening of 
nonsustained ventricular tachycardia necessitating changes 
in anliatrhylhmic therapy. From our study and others 
(7,9,10,21L it appears that clinically stgnificant worsening of 
arrhythmia is not uncommon after defibrillator implantation. 
Surgical mortality after implantation is frequenaly due to the 
aggravation of ventricular arrhythmia or the appearance of 
incessant ventricular tachycardia or ventricular fibrillation. 
Our study also repons a marked Isevenfold) increase in 
asymptomatic ventricular premature complexes (20) in the 
remaining clinically stable patients. Although the clinical 
significance of the asymptomatic increase in ventricular 
arrhythmias is unknown. no other studies have been done to 
quantitatively compare ventricular arrhythmias noted before 
and after operation. 
Mechanisms of the arrhythmogettesis. This study suggests 
that implantation of currently available defibrillator and 
electrode lead systems or the operation associmed with 
implantation may aggravate ventricular arrhythmias in some 
patients. The cause of this aggravation is unknown. If it IS 
related to mechamcal irritation or mflammation after the 
procedure. future generations of defibrillators using subcu- 
taneous patch electrodes may not be associated with such 
problems. 
Merabolic arrd &cI~oI~~~ chaes drrriw r/w immediate 
posroprmriw period may have played a ml* in the worsen- 
ing of arrhythmias in some patients. although in many 
patients the recurrence of sustained ventricular tachycardia 
was noted several days to weeks after the operation with 
adequate blood levels of antiarrhythmic drugs and normal 
sewn electrolytes ITables I and 2). In addition. ambulatory 
ECG monitoring performed 9 f 5 days after surgery in 
clinically stable patients showed a significant increase in 
ventricularectopic activity, further suggestingthat the was- 
cning may not be solely due to postoperative transient 
metabolic and electrolyte changes. However. it is possible 
that serum electrolyte changes. ischemia or pericarditis may 
have played some role in the arrhythmogeneis. Atrial 
arrhythmias commonly associated with postoperative peri- 
carditis were freauentlv noted in our !xttients. However. no 
correlation bet&n &al arrhythmia; and the worsening of 
ventricular arrhythmia could be established in this study. 
It is unclear why in most patients, the onset of sus- 
tained arrhythmias was noted several days postopratively 
(Table IL 
One may argue that a concomitant operation such as 
coronary bypass grafting may be responsible for the wars- 
enine. However, no patient in erour, I had a concomitant 
op&tion. In addition. although th; 20 patients who had 
coronary bypass grafting without defibrillator implantation 
also had a slight increase in ventricular arrhythmias postop- 
eratively, the increzse was not as significant as that noted in 
the group I patients or in the 12~patients who had both 
defibrillator implantation and coronary bypass grafting. 
Regardless of the mechanism of the worsening of atrhyth- 
miss. the worsening is clinically significant in many patients 
and in some leads to in-hospital death during the postoper- 
alive period as shown in this study and others (7.10.21). 
It is also unknown if the worsening of arrhythmia noted 
during the short-term follow-up period has any long-term 
effects. Further studies are necessary to determine the 
mechanism of the aggravation af arrhythmia and the long- 
term prognostic significance. 
Study pmtwol. The study patients were classified into 
two groups and analyzed separately to exclude possible 
effects ofamcomitant w&on the postoperative~course. 
However, the incidence of clinically significant worsening of 
arrhythmias was similar in the two groups. Such worse& 
was defined as recurrence of ventricular tachycardia or 
frequent nonsustained ventricular tachycardia that required 
an additional antiarrhythmic agent in patients who had been 
in stable conditton preoperatwely. Eight patvznt> wth a 
recurrence had been in stable condition ulthout wm~ul,~ 
tachycardia for 219 + 25 days trange I? w 601 :xlorc 
operation and had multiple rec”rre”CeS 4 * 9 day, pwtap- 
crativelv to < 0.051 (Table II. 
War&& of arrhythmia noted after an rmplamarlon of a 
defibrillator was defined bv ambulavxv ECG moniiormc rn 
the remaining 35 panem;. The &al r~gmticance if a 
marked (sevenfold) increase in the frequency of aympto- 
matic ventricular arrhythmias noted during ambulatory mon- 
itoring is unclear. However. the mtrcase nored pastopera- 
lively is unlikely :o be due to the day to da) variation\ in rhe 
frequency of ventrixdar premature complew m WC of the 
stringent criterion used in this wdy that wili propwed hv 
other investigicors ,201 to exclude such poabdit? ofday IO 
day variations. 
Limitations of the study. The relatively small number of 
patients in group L is a limit&on. Howver. no other 
investigation has addressed the issue systematically md 
further studies in a larger group of patwntr ~11 be needed to 
confirm or repudiate our findings. Our uudy doe\ not 
address the long-term effects of the woneninp of ventricular 
arrhythmias noted. Although the worsening appeared to be 
transient and the previously chosen antiarrhythmr regimen 
could be reinstituted in soroe oatients. mo,r of the tx~ltw~ts 
received an additional or 8 different agnt powpcratively. 
making it difficult to determine if the worxoing was trao- 
sient. Additional studies to answer this question m’y be 
dit%cult to conduct becaure the outcome of patientr treated 
with defibrillator implantation needs to be compared with 
that of similar patients treated with smtilar drups without a 
defibrillator. 
Clinical implications. The rcwlts of thic study do not 
negate the value of the automatic tmplantable defibrillator m 
the management of patients wth mnlignnnt arrhythmia\. 
Additional studies may identify the mcchani~m for the 
worsening of the arrhythmias and comet the problem. 
However. when choosing a patient for defibrillator therapy 
and interpreting the results of clinical follow-up of patients 
treated with an implantable defibrillator. &t should be borne 
in mind that the current technology of implantation may 
change the clinical course of patients. The urgical mortality 
rate is not insignificant (7.9.21) and is frequently due to the 
development of incessant ventrndar tachycnrde during the 
poslap&ative period (7.10.21). In addition. it IS posrtble that 
the exacerbation of arrhythmia noted during this period may 
have long-term effects. Therefore. the rate of recurrence of 
malignant arrhythmias in patient, with an implantable de- 
fibrillator may not reflect the true rate of rccwrence of 
malignant arrhythmias in those patients 1reate.i WI& :he 
same medical regimen wthout a defibrillator. 
Beeaise of the many reports of very low rate> of sudden 
death in oatients treated wth a defibrillator. wme mvc~tiw 
tars (22.231 have sugge\ted tha 111 patan wilt, w!tric& 
tachycudia or vcntriculsr fibnllation should be treated tilth 
an implantable defibrdlator even when an ellectwc regamen 
b) programmed stimulation criteria could bc tdcnrdied. 
Their arpumsnt may bc bared on the fact ihat reported 
wdden death rrrec m patients treated with an implsntable 
de6hrillaror arc oiten lower than ,hose m paems tiea,ed 
nnh annar;hythm~c drugs that prevented induction of wn- 
~nculx tachicardra by programmed stlmulatmo WI. Such 
ar~wne~t sugge\rinx obsJoxwce OF elecrrophysmlogic 
rtwbe\ may not be valid l?El. not only because the sudden 
death we o~erestm~ates the benefit, of def,btillator theraov 
b) nut including the wrgical mortality and arrhythm;~. 
reialcd non\uddcn deaths (?b.27). hut also because dsfibnl- 
later therapy mdy alter rhe natural coune of the di,ea,e 
prow, m \omc pat~ems by aggnvatmg the arrhythmias ar 
addrcwd in thir wdy. 
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